Nonadherence in inflammatory bowel disease: Results of factor analysis

Inflammatory Bowel Diseases

Volumn 13, Issue 10, 2007, Pages 1244-1249

  Červený, Petr ^a   Bortlík, Martin ^b   Kuběna, Aleš ^a   Vlček, Jiří ^a   Lakatos, Peter Laszlo ^c   Lukáš, Milan ^b  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Crohn's disease; Mesalamine; Patient compliance; Ulcerative colitis

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; MESALAZINE;

ADULT; ARTICLE; EDUCATION; FACTORIAL ANALYSIS; FEMALE; HUMAN; INFLAMMATORY DISEASE; INTERVIEW; INTESTINE SURGERY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SMOKING; ULCERATIVE COLITIS; URINALYSIS;

ADOLESCENT; ADULT; AGED; AMINOSALICYLIC ACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FACTOR ANALYSIS, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MESALAMINE; MIDDLE AGED; PATIENT COMPLIANCE; PROGNOSIS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT REFUSAL;

EID: 35348958502     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20189     Document Type: Article

References (15)

1. van Hees PA, van Tongeren JH. Compliance to therapy in patients on a maintenance dose of sulfasalazine. J Clin Gastroenterol. 1982;4:333-336.
2. Riley SA, Mani V, Goodman MJ, et al. Why do patients with ulcerative colitis relapse? Gut. 1990;31:179-183.
3. Kane SV, Cohen RD, Aikens JE, et al. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol. 2001;96:2929-2933.
4. Sewitch MJ, Abrahamowicz M, Barkun A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol. 2003; 98:1535-1544.
5. Shale MJ, Riley SA. Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2003;18:191-198.
6. Kane S, Huo D, Aikens J, et al. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med. 2003; 114:39-43.
7. Lopez San Roman A, Bermejo F, Carrera E, et al. Adherence to treatment in inflammatory bowel disease. Rev Esp Enferm Dig. 2005;97: 249-257.
8. Kane SV. Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment Pharmacol Ther. 2006;23:577-585.
9. Vermeire E, Hearnshaw H, Van Royen P, et al. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26:331-342.
10. Levy RL, Feld AD. Increasing patient adherence to gastroenterology treatment and prevention regimens. Am J Gastroenterol. 1999;94:1733-1742.
11. Miller NH. Compliance with treatment regimens in chronic asymptomatic diseases. Am J Med. 1997;102:43-49.
12. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001; 23:1296-1310.
13. Levy G. Medication non-compliance - when hard science meets soft science. Int Congress Ser. 2001;1220:125-133.
14. Nobilis M, Vybiralova Z, Sladkova K, et al. High-performance liquid-chromatographic determination of 5-aminosalicylic acid and its metabolites in blood plasma. J Chromategr A. 2006;1119:299-308.
15. Sheshkin D. Handbook of parametric and nonparametric statistical procedures, 3rd ed. Boca Raton, FL: CRC Press; 2004.